A. Eerenberg-Belmer

发表

Increased plasma levels of interleukin-6 in sepsis.

L A Aarden, C. Hack, L. Thijs, 1989, Blood.

Increased plasma levels of interleukin-6 in sepsis [see comments]

L. G. Thijs, L. A. Aarden, C. Hack, 1989 .

Renal cell carcinoma and interleukin-2: a review.

J. Baars, J. Wagstaff, C. Hack, 1995, European journal of cancer.

Activation of the contact system of coagulation by a monoclonal antibody directed against a neodeterminant in the heavy chain region of human coagulation factor XII (Hageman factor).

C. Hack, J. Nuijens, A. Eerenberg-Belmer, 1989, The Journal of biological chemistry.

Proteolytic inactivation of plasma C1- inhibitor in sepsis.

C. Hack, L. Thijs, J. Nuijens, 1989, The Journal of clinical investigation.

Activation of the complement system during immunotherapy with recombinant IL-2. Relation to the development of side effects.

C. Hack, L. Thijs, R. S. V. STRACK VAN SCHIJNDEL, 1990, Journal of immunology.

Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.

C. Hack, A. Eerenberg-Belmer, R. Aalberse, 1984, Arthritis and rheumatism.

Interleukin‐2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia

J. Baars, J. Wagstaff, C. Hack, 1992, British journal of haematology.

The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2.

J. Baars, C. Hack, L. Thijs, 1992, British Journal of Cancer.

Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis.

C. Hack, L. Thijs, R. S. V. STRACK VAN SCHIJNDEL, 1988, Blood.

Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis.

C. Hack, L. Thijs, J. Nuijens, 1989, The American journal of medicine.

Heparin-protamine Complexes and C-reactive Protein Induce Activation of the Classical Complement Pathway: Studies in Patients Undergoing Cardiac Surgery and In Vitro

C. Hack, E. Hack, P. Bruins, 2000, Thrombosis and Haemostasis.

Corning's "Ice-Water Cap" for Congestive Headaches

C. Delclaux, A. Cariou, M. Delpech, 2010 .

Proteolytic Inactivation ofPlasmaClInhibitor inSepsis

L. Thijs, E. Hack, J. Nuijens, 1989 .

Administration of C1 Inhibitor Reduces Neutrophil Activation in Patients with Sepsis

C. Hack, A. Eerenberg-Belmer, S. Zeerleder, 2003, Clinical Diagnostic Laboratory Immunology.

Activated cytotoxic T cells and NK cells in severe sepsis and septic shock and their role in multiple organ dysfunction.

C. Hack, A. Eerenberg-Belmer, A. Wolbink, 2005, Clinical immunology.

Polyethylene glycol enhances the binding of C1q to circulating immune complexes.

C. Hack, T. Out, A. Eerenberg-Belmer, 1981, Journal of immunological methods.

A C1-inhibitor-complex assay (INCA): a method to detect C1 activation in vitro and in vivo.

T. Out, A. Eerenberg-Belmer, R. Aalberse, 1981, Journal of immunology.

Angioneurotic oedema and urticaria during therapy with interleukin-2 (IL-2).

J. Baars, J. Wagstaff, C. Hack, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

SLE like syndrome and functional deficiency of C1q in members of a large family.

A. Eerenberg-Belmer, C. E. Hack, J. Kluin-Nelemans, 1984, Clinical and experimental immunology.

A progress report of a phase I study of interferon-gamma and interleukin-2 and some comments on the mechanism of the toxicity due to interleukin-2.

C. Hack, J. Wagstaff, J. Nuijens, 1989, Cancer treatment reviews.

The release of interleukin-8 during intravenous bolus treatment with interleukin-2.

J. Baars, J. Wagstaff, C. Hack, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.